Novo Nordisk layoffs have started in Denmark, where the drugmaker plans to cut 5,000 jobs as part of 9,000 global redundancies announced in early September 2025. The process began this
An increasing share of Ozempic prescriptions in Denmark is being purchased without public subsidy, with patients covering the full cost themselves. According to data from the Danish Health Data Authority
Novo Nordisk, the Danish pharmaceutical giant renowned for its diabetes and obesity treatments, experienced its largest stock decline ever, with shares plummeting 23.11% in a single day. This dramatic fall